Clinical Trials in New York

Showing 9021-9040 of 19,464 trials

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

NCT03241173

The purpose of this study is to determine the safety, tolerability, and efficacy of INCAGN01949 when given in combination with immune therapies in participants with advanced or metastatic malignancies.

Advanced Malignancies

Incyte Biosciences International Sàrl52 participantsStarted Oct 2017

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Los Angeles, California, United States +12 more locations

COMPLETEDPhase 1/2< 1 mile

Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

NCT02024087

The purpose of this study is to evaluate the safety and tolerability of dalantercept plus sorafenib in patients with advanced hepatocellular carcinoma (HCC) to determine the recommended dose level of dalantercept in combination with sorafenib.

Advanced Adult Hepatocellular Carcinoma

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA21 participantsStarted Aug 2014

Chicago, Illinois, United States • Westwood, Kansas, United States • Boston, Massachusetts, United States +4 more locations

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Find Trials by Condition in New York

Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease

A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Natural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD

Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies.

Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma

A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)

A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma

Evaluation of PSMA Antagonist Produced by Two Different Methods

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.

Implantation of the Cochlear® Nucleus® System in Adults With Single-Sided Deafness

Effects of Pneumatic Vitreolysis on Vitreomacular Traction

Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma

Open Label Study of Long Term Evaluation Against LDL-C Trial

Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing

A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

SAR3419 in Acute Lymphoblastic Leukemia

Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)